3-methoxymorphinan has been researched along with Seizures in 1 studies
3-methoxymorphinan: dextromethorphan metabolite; RN & N1 from 9th CI Form Index; RN given refers to cpd without isomeric designation; structure in first source
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HC | 1 |
| Shin, CY | 1 |
| Seo, DO | 1 |
| Jhoo, JH | 1 |
| Jhoo, WK | 1 |
| Kim, WK | 1 |
| Shin, EJ | 1 |
| Lee, YH | 1 |
| Lee, PH | 1 |
| Ko, KH | 1 |
1 other study available for 3-methoxymorphinan and Seizures
| Article | Year |
|---|---|
New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.
Topics: Animals; Anticonvulsants; Dextromethorphan; Dose-Response Relationship, Drug; Electroshock; Injectio | 2003 |